A carregar...
Expression of EZH2 is associated with poor outcome in colorectal cancer
Enhancer of zeste homolog 2 (EZH2), the critical component of polycomb group protein family, has been demonstrated to be overexpressed in various types of human cancer, including hepatocellular carcinoma, breast, bladder and lung cancer. The mechanism of how EZH2 promotes oncogenesis has also been w...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5778885/ https://ncbi.nlm.nih.gov/pubmed/29435024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7647 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|